Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Sep;21(9):1558-63.
doi: 10.1023/b:pham.0000041448.22771.48.

Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization

Affiliations

Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization

Valérie-Gaëlle Roullin et al. Pharm Res. 2004 Sep.

Abstract

Purpose: To determine (i) the efficiency of radiosensitizing 5-FU-loaded microspheres and (ii) the impact of microparticle formulation on response to treatment.

Methods: C6 tumor-bearing rats were stereotactically implanted with microspheres and/or allocated to: control groups (untreated) or treatment (only radiotherapy; fast-release 5-FU microspheres + radiotherapy; slow-release 5-FU microspheres + radiotherapy). The next day, fractionated radiotherapy, limited to the hemibrain, was initiated in all treated animals. The irradiation cycle included 36 Gy, given in 9 sessions for 3 consecutive weeks. Tumor development was assessed by T2-weighted MRI.

Results: 5-FU microspheres associated with radiotherapy caused a 47% complete remission rate (9/19) as opposed to the 8% rate (1/12) when radiotherapy alone or 0% in control animals. Drug delivery for 3 weeks produced better survival results (57%) compared to one-week sustained release (41%). MR images showed exponentially increasing tumor volumes during the first half of the radiotherapy cycle, followed by a decrease, and the disappearance of the tumor if survival exceeded 120 days.

Conclusions: 5-FU controlled delivery is a promising strategy for radiosensitizing gliomas. Drug delivery system formulation is unambiguously implicated in both the response to treatment and the limitation of toxic side effects.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharm Biopharm. 2003 Sep;56(2):271-9 - PubMed
    1. NMR Biomed. 2001 Oct;14(6):360-6 - PubMed
    1. Cancer. 1999 Jul 15;86(2):325-30 - PubMed
    1. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12 ):7012-7 - PubMed
    1. Cancer. 2000 May 15;88(10):2350-6 - PubMed

Publication types

LinkOut - more resources